Triforge Tablet

About Triforge Tablet

Triforge Tablet Uses

• Treatment of hypertension (high blood pressure) in adults whose blood pressure is not adequately controlled on two medications alone.
• Reduction of the risk of fatal and non-fatal cardiovascular events including stroke and heart attack in hypertensive patients.
• Management of hypertension in patients who have already been stabilized on the individual components at the same doses.
• Prevention of certain types of chest pain (stable angina pectoris) in patients where Amlodipine is clinically appropriate.
• Management of hypertension in patients with concomitant conditions such as type 2 diabetes or chronic kidney disease where blood pressure control is critical.

Triforge Tablet Benefits

• Three active ingredients in one tablet simplify the daily regimen, improving treatment adherence compared to taking three separate medicines.
• Targets blood pressure through three distinct mechanisms simultaneously, providing more complete control than single or dual-agent therapy.
• Reduces fluid retention caused by Amlodipine through the diuretic action of Hydrochlorothiazide, minimizing ankle swelling.
• Valsartan component provides additional protection against heart failure and kidney disease progression beyond blood pressure lowering alone.
• Effective around the clock with once-daily dosing, maintaining consistent 24-hour blood pressure control.

What Experts Say

Triforge combines three antihypertensive agents that act through entirely different physiological pathways, making the combination clinically superior to adding higher doses of any single agent. Amlodipine is a dihydropyridine calcium channel blocker. It blocks L-type calcium channels in vascular smooth muscle cells, preventing calcium influx that causes vasoconstriction. The result is arterial vasodilation, reduced peripheral vascular resistance, and lower blood pressure. Amlodipine also reduces coronary vasospasm, which is why it is effective in stable angina.

Valsartan is an angiotensin II receptor blocker (ARB) that selectively antagonizes the AT1 receptor subtype. By blocking angiotensin II binding, it prevents vasoconstriction, aldosterone release, and sodium retention that the renin-angiotensin-aldosterone system (RAAS) drives. This mechanism is particularly protective in patients with diabetes or kidney disease, where RAAS overactivation accelerates organ damage. Hydrochlorothiazide is a thiazide diuretic that inhibits sodium chloride reabsorption in the distal convoluted tubule of the kidney. This promotes urinary sodium and water excretion, reducing plasma volume and consequently lowering blood pressure.

The three-way combination is indicated when dual therapy fails to achieve target blood pressure. Clinical guidelines support fixed-dose triple combinations for improving adherence in patients requiring multiple antihypertensives. Clinicians should be aware that Hydrochlorothiazide may cause electrolyte imbalances, particularly hypokalemia, hyponatremia, and hypomagnesemia, especially in elderly patients. Potassium levels and renal function should be monitored regularly during treatment.

Drug Class

• Antihypertensive (Triple Combination).
• Amlodipine: Calcium Channel Blocker (CCB).
• Valsartan: Angiotensin II Receptor Blocker (ARB).
• Hydrochlorothiazide: Thiazide Diuretic.

Packaging and Quantity

• 1 pack contains 28 tablets.
• Packaged as 4 blister strips of 7 tablets each.
• Available in five strength combinations from 5mg/160mg/12.5mg to 10mg/320mg/25mg.

When Not to Use Triforge

• Known allergy or hypersensitivity to Amlodipine, Valsartan, Hydrochlorothiazide, or any sulfonamide-derived medicine.
• Pregnancy, as Valsartan and Hydrochlorothiazide can cause fetal harm and death.
• Severe liver disease or biliary cirrhosis.
• Severe kidney impairment (creatinine clearance below 30 mL per minute) or anuria.
• Concurrent use of Aliskiren in patients with diabetes or renal impairment.
• Refractory hypokalemia, hyponatremia, hypercalcemia, or symptomatic hyperuricemia.

Triforge Tablet formula

• Amlodipine + Hydrochlorothiazide + Valsartan

Available forms

• Tablets

How to use Triforge Tablet?

• Triforge may be taken with or without food.
• The tablet should be swallowed whole with a full glass of water.
• This medicine should be taken at the same time each day to maintain consistent blood pressure control.
• If taken too close to bedtime, the diuretic effect of Hydrochlorothiazide may cause nighttime urination. Taking it at least 4 hours before bedtime is recommended.
• Blood pressure should be monitored regularly during treatment.
• The standard adult dose is 1 tablet once daily, using the strength as clinically determined by the prescribing doctor.
• The dose should not be changed or stopped without consulting a doctor, as sudden discontinuation can cause a rebound rise in blood pressure.

Drug Interactions

Each of the three active ingredients in Triforge has its own interaction profile. All current medicines, supplements, and herbal products must be disclosed to the prescribing doctor before starting Triforge. Key interactions include:

• Aliskiren: concurrent use with Valsartan is contraindicated in patients with diabetes or renal impairment due to the risk of severe hypotension, hyperkalemia, and kidney failure.
• ACE inhibitors such as lisinopril and enalapril: combining with Valsartan doubles RAAS blockade, significantly increasing the risk of hypotension, hyperkalemia, and kidney impairment.
• Potassium supplements and potassium-sparing diuretics: Hydrochlorothiazide lowers potassium while Valsartan raises it. Combining with additional potassium raises the risk of hyperkalemia.
• Lithium: Hydrochlorothiazide reduces kidney clearance of lithium, raising lithium blood levels and the risk of toxicity.
• NSAIDs such as ibuprofen and naproxen: reduce the antihypertensive effect of all three components and increase the risk of kidney impairment.
• Cholestyramine and colestipol: reduce absorption of Hydrochlorothiazide. Triforge should be taken at least 4 hours before or 4 to 6 hours after these medicines.
• Antidiabetic medicines: Hydrochlorothiazide may raise blood sugar, requiring dose adjustment of insulin or oral hypoglycemic agents.
• Ciclosporin: Amlodipine may increase ciclosporin blood levels, raising the risk of toxicity.
• Simvastatin: Amlodipine inhibits CYP3A4 and can increase simvastatin blood levels. The simvastatin dose should not exceed 20mg daily when taken with Amlodipine.

Risks and warnings

• Pregnancy: Triforge is contraindicated in pregnancy. Valsartan and Hydrochlorothiazide can cause fetal harm including renal failure and death. Treatment must be stopped immediately if pregnancy is detected.
• Breastfeeding: Hydrochlorothiazide and Amlodipine pass into breast milk. Breastfeeding is not recommended during treatment with Triforge.
• Kidney disease: Triforge should be used with caution in patients with renal impairment. It is contraindicated in severe renal impairment. Kidney function and electrolytes must be monitored regularly.
• Liver disease: Amlodipine and Valsartan are metabolized by the liver. Patients with severe hepatic impairment should not use Triforge.
• Electrolyte imbalances: Hydrochlorothiazide can cause hypokalemia, hyponatremia, and hypomagnesemia, particularly in elderly patients. Electrolyte levels must be monitored during treatment.
• Hyperkalemia: Valsartan can raise potassium levels. The risk increases when combined with potassium supplements, ACE inhibitors, or potassium-sparing diuretics.
• Hypotension: Triforge can cause symptomatic low blood pressure, particularly in volume-depleted patients or those on high-dose diuretics. Volume depletion should be corrected before starting treatment.
• Diabetes: Hydrochlorothiazide may impair glucose tolerance and raise blood sugar levels. Diabetic patients should monitor blood glucose closely during treatment.
• Gout: Hydrochlorothiazide can raise uric acid levels and may trigger gout attacks in susceptible patients.
• Driving and machinery: Triforge may cause dizziness and fatigue, particularly at the start of treatment. Caution is advised when driving or operating heavy machinery.

Triforge Tablet Side Effects

Most patients tolerate Triforge well at the recommended dose. Side effects, when they occur, are generally mild and often improve as the body adjusts to treatment.

• Dizziness or lightheadedness, particularly when standing up quickly.
• Ankle or leg swelling caused by Amlodipine.
• Flushing or a sensation of warmth in the face.
• Fatigue or tiredness.
• Nausea or mild stomach discomfort.
• Increased urination, particularly in the first few weeks of treatment due to Hydrochlorothiazide.
• Muscle cramps caused by electrolyte changes.

Serious side effects are rare. Medical attention should be sought immediately if any of the following occur:

• Severe dizziness or fainting, which may indicate a significant drop in blood pressure.
• Swelling of the face, lips, tongue, or throat, which may indicate angioedema, a rare but serious reaction associated with Valsartan.
• Signs of high potassium including muscle weakness, slow or irregular heartbeat, or numbness.
• Signs of low sodium including severe headache, confusion, seizures, or muscle weakness.
• Signs of kidney impairment including significantly reduced urination or unusual swelling.
• Chest pain or worsening breathlessness.
• Yellowing of the skin or eyes, which may indicate liver involvement.

Storage Conditions

• Store at room temperature, below 25°C.
• Keep away from direct sunlight, heat, and moisture.
• Store in the original blister packaging to protect from humidity.
• Keep out of reach and sight of children.
• Do not use after the expiry date printed on the packaging.
• Do not store in the bathroom or near a kitchen sink.